Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 1/20 | 0.47 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.46 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.43 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.43 |
| ▸ | LTA4H | P09960 | 1/20 | 0.43 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.43 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.42 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.42 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.42 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.41 |
| ▸ | HRH1 | P35367 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5690175 | 1.00 | BCHE (0.47) | BCHEFFAR4GRIN2BGRIN1LTA4H | |
| SCHEMBL5691624 | 0.94 | BCHE (0.49) | BCHEGRIN2BGRIN1LTA4HEPHX2 | |
| SCHEMBL5691626 | 0.94 | BCHE (0.49) | BCHEGRIN2BGRIN1LTA4HEPHX2 | |
| SCHEMBL5689775 | 0.88 | KDM4E (0.45) | LTA4HKDM4EMRGPRX4 | |
| SCHEMBL5689857 | 0.88 | KDM4E (0.45) | LTA4HKDM4EMRGPRX4 | |
| SCHEMBL5689337 | 0.82 | SPHK1 (0.49) | GRIN2BALOX5KDM4ESPHK1 | |
| SCHEMBL5689334 | 0.82 | SPHK1 (0.49) | GRIN2BALOX5KDM4ESPHK1 | |
| SCHEMBL5690074 | 0.81 | KDM4E (0.49) | LTA4HKDM4EMRGPRX4 | |
| SCHEMBL5690071 | 0.81 | KDM4E (0.49) | LTA4HKDM4EMRGPRX4 | |
| SCHEMBL5689418 | 0.81 | MRGPRX4 (0.50) | GRIN2BGRIN1LTA4HEPHX2ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0982026-B1 | Use of aryl-cyclohexylamine derivatives in the manufacture of NMDA receptor blockers | HOFFMANN LA ROCHE (CH) | 2006-05-17 | — | — | EP | disclosed |
| US-6184236-B1 | Method of treating a neurodegenerative disease by administering an aryl-cyclohexylamine derivative | HOFFMANN-LA ROCHE INC. | 2001-02-06 | — | — | US | disclosed |
| EP-0982026-A2 | Use of aryl-cyclohexylamine derivatives in the manufacture of NMDA receptor blockers | F. HOFFMANN-LA ROCHE AG (CH) | 2000-03-01 | — | — | EP | disclosed |